Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly

Annals of Internal Medicine

Volumn 117, Issue 8, 1992, Pages 625-633

  Treanor, John J ^a   Mattison, H Reid ^a   Dumyati, Ghinwa ^a   Yinnon, Amos ^a   Erb, Shirley ^a   O'Brien, Diane ^a   Dolin, Raphael ^a   Betts, Robert F ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE; LIVE VACCINE; PLACEBO; TRIPLE VACCINE;

AGED; ANTIBODY RESPONSE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INFECTION PREVENTION; INFLUENZA VIRUS A; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NOSE SECRETION; NOSE SMEAR; NURSING HOME; PRIORITY JOURNAL; RANDOMIZATION; VIRUS ISOLATION;

ADMINISTRATION, INTRANASAL; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; DISEASE OUTBREAKS; DOUBLE-BLIND METHOD; FEMALE; HOMES FOR THE AGED; HUMAN; INFLUENZA; INFLUENZA A VIRUS, HUMAN; INFLUENZA VACCINE; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGE; NURSING HOMES; SUPPORT, U.S. GOV'T, P.H.S.; VACCINES, ATTENUATED; VACCINES, INACTIVATED;

EID: 0026782651     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-117-8-625     Document Type: Article

References (46)

1. Barker WH. Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States. Am J Public Health. 1986;76:761-5.
2. Williams WW, Hickson MA, Kane MA, Kendal AP, Spika JS, Hinman AR. Immunization policies and vaccine coverage among adults: the risk for missed opportunities. Ann Intern Med. 1988;108:616-25.
3. Barker WH, Mullooly JP. Pneumonia and influenza deaths during epidemics: implications for prevention. Arch Intern Med. 1982;142: 85-9.
4. Barker WH, Mullooly JP. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol. 1980;112:798-811.
5. Barker WH, Mullooly JP. Influenza vaccination of elderly persons: reduction in pneumonia and influenza hospitalizations and deaths. JAMA. 1980;244:2547-9.
6. Barker WH, Mullooly JP. Effectiveness of inactivated influenza vaccine among non-institutionalized elderly persons. In: Kendal AP, Patriarca PA; eds. Options for the Control of Influenza. New York: Alan R. Liss;1986:169-82.
7. Betts RF, Dolin R, Treanor JJ, Roth FK, O'Brien D, Erb S. Inactivated influenza vaccine reduces frequency and severity of illness in the elderly [abstract]. In: Program and Abstracts of the 24th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1984 Oct 8-10; Washington D.C.: American Society for Microbiology 1984; Abstract 289.
8. Gross PA, Quinnan GV, Rodstein M, Lamontagne JR, Kastow RA, Saah AJ, et al. Association of influenza immunization with reduction in mortality in an elderly population. Arch Intern Med. 1988; 148:562-5.
9. Patriarca PA, Weber JA, Rarker RA, Hall WN, Kendal AP, Bregman DJ, et al. Efficacy of influenza vaccine in nursing homes: reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA. 1985;253:1136-9.
10. Patriarca PA, Weber JA, Parker RA, Orenstein WA, Hall WN, Kendal AP, et al. Risk factors for outbreaks of influenza in nursing homes: a case-control study. Am J Epidemiol. 1986;124:114-9.
11. Feery BJ, Evered MG, Morrison EI. Different protection rates in various groups of volunteers given subunit influenza virus vaccines in 1976. J Infect Dis. 1979;139:237-41.
12. Saab AJ, Neufeld R, Rodstein M, LaMontagne JR. Blackwelder WC, Gross P, et al. Influenza vaccine and pneumonia mortality in a nursing home population. Arch Intern Med. 1986;146:2353-7.
13. Carter ML, Renzullo PO, Helgerson SD, Martin SM, Jekel JF. Influenza outbreaks in nursing homes: how effective is influenza vaccine in the institutionalized elderly? Infect Control Hosp Epidemiol. 1986;11:473-8.
14. Arden NH, Patriarca PA, Kendal AP. Experiences in the use and efficacy of inactivated influenza vaccine in nursing homes. In: Kendal AO, Patriarca PA; eds. Options for the Control of Influenza. New York: Alan R. Liss;1986:155-168.
15. Arroyo JC, Postic B, Brown A, Harrison K, Birgenheier R, Dowda H. Influenza A/Philippines/2/82 outbreak in a nursing home: limitations of influenza vaccination in the aged. Am. J Infect Control. 1984;12:329-34.
16. Ruben FL, Johnston F, Streiff EJ. Influenza in a partially immunized aged population: effectiveness of killed Hong Kong Vaccine against infection with the England Strain. JAMA. 1974;230:863-6.
17. Horman JT, Stetler HC, Israel E, Sorley D, Schipper MT, Joseph JM. An outbreak of influenza A in a nursing home. Am J Public Health. 1986;76:501-4.
18. Maassab HF, DeBorde DC. Development and characterization of cold-adapted viruses for use as live virus vaccines. Vaccine. 1985; 3:355-69.
19. Cox NJ, Kitame F, Kendal AP, Maassab HF, Naeve C. Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60. Virology. 1988;167:554-67.
20. Snyder MH, Betts RF, DeBorde D, Tierney EL, Clements ML, Herrington D, et al. Four viral genes independently contribute to the attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines. J Virol. 1988;62:488-95.
21. Johnson PR, Feldman S, Thompson JM, Mahoney JD, Wright PF. Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. J Infect Dis. 1986;154:121-7.
22. Johnson PR, Feldman S, Thompson JM, Mahoney JD, Wright PF. Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine. J Med Virol. 1985;17:325-35.
23. Anderson EL, Belshe RB, Burk B, Bartram J, Maassab HF. Evaluation of cold-recombinant influenza A/Korea (CR-59) virus vaccine in infants. J Clin Microbiol. 1989;27:909-14.
24. Belshe RB, Van Voris LP, Bartram J, and Crookshanks FK. Live attenuated influenza A virus vaccines in children: results of a field trial. J Infect Dis. 1984;150:834-40.
25. Betts RF, Douglas RG, and Murphy BR. Resistance to challenge with influenza A/Hong Kong/123/77 (H1N1) wild-type virus induced by live attenuated A/Hong Kong/123/77 (H1N1) cold-adapted reassortant virus. J Infect Dis. 1985;151:744-5.
26. Clements ML, Belts RF, Murphy BR. Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection. Lancet. 1984;1:704-8.
27. Clements ML, Belts RF, Tierney EL, and Murphy BR. Resistance of adults to challenge with influenza A wild-type virus after receiving live or inactivated virus vaccine. J Clin Microbiol. 1986;23:73-6.
28. Sears SD, Clements ML, Betts RF, Maassab HF, Murphy BR, Snyder MH. Comparison of live attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults. J Infect Dis. 1988;158:1209-18.
29. Murphy BR, Chanock RM, Clements ML, Anthony WC, Sear AJ, Cisneros LA, et al. Evaluation of A/Alaska/6/77 (H3N2) cold-adapted recombinant viruses derived from A/Ann Arbor/6/60 cold-adapted donor virus in adult seronegative volunteers. Infect Immun. 1981;32:693-7.
30. Hall CB, Douglas RG Jr. Respiratory syncytial virus and influenza: practical community surveillance. Am Jour Dis Child. 1976;130:615-20.
31. Madore HP, Reichman RC, Dolin R. Serum antibody responses in naturally occurring influenza A virus infection determined by enzyme-linked immunosorbent assay, hemagglutination inhibition, and complement fixation. J Clin Microbiol. 1983;18:1345-50.
32. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research: Principles and Quantitative Methods. 1982, Lifetime Learning Publications, Belmont, California.
33. Anonymous. Prevention and control of influenza. Recommendations of the immunization practices advisory committee (ACIP). MMWR. 1990;39 RR 7:1-15.
34. Falsey AR, Treanor JJ, Betts RF, Walsh EE. Viral Respiratory Infections in the Institutionalized Elderly: Clinical and Epidemiological Findings. J Am Ger Soc. 1992;40:115-9.
35. Budnick LD, Stricof RL, Ellis F. An outbreak of influenza A in a nursing home, 1982. N Y State J Med. 1984;84:235-8.
36. Powers DC, Sears SD, Murphy BR, Thumar B, Clements ML. Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines. J Clin Microbiol. 1989;27: 2666-71.
37. Gorse GJ, Belshe RB, Munn NJ. Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases. J Clin Microbiol. 1986;24:336-42.
38. Gorse GJ, Belshe RB, and Munn NJ. Local and systemic antibody responses in high-risk adults given live attenuated and inactivated influenza A virus vaccines. J Clin Microbiol. 1986;26:911-8.
39. Powers DC, Fries LF, Murphy BR, Thumar JB, Clements ML. In elderly persons live attenuated influenza A virus vaccines do not offer an advantage over inactivated virus vaccine in inducing serum or secretory antibodies or local immunologic memory. J Clin Microbiol. 1991;29:498-505.
40. Gorse GJ, Belshe RB. Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill adults. J Clin Microbiol. 1990;28:2539-50.
41. Gorse GJ, Belshe RB. Enhanced lymphoproliferation to influenza a virus following vaccination of older chronically ill adults with liveattenuated viruses. Scand J Infect Dis. 1990;23:7-16.
42. Gross PA, Rodstein M, LaMontagne JR, Kaslow RA, Saah AJ, Wallenstein S, et al. Epidemiology of acute respiratory illness during an influenza outbreak in a nursing home. Arch Intern Med. 1988; 148:559-61.
43. Mathur U, Bentley DW, Hall CB. Concurrent respiratory syncytial virus and influenza A infections in the institutionalized elderly and chronically ill. Ann Intern Med. 1980;93:49-52.
44. Atmar RL, Bloom K, Keitel W, Couch RB, Greenberg SB. Effect of live attenuated cold recombinant (CR) influenza virus vaccines on pulmonary function in healthy and asthmatic adults. Vaccine. 1990; 8:217-24.
45. Snyder MH, London WT, Maassab HF, Murphy BR. Attenuation and phenotypic stability of influenza B/Texas/1/84 cold-adapted reassortant virus: studies in hamsters and chimpanzees. J Infect Dis. 1989;160:604-10.
46. Clements ML, Snyder MH, Sears SD, Maassab HF, Murphy BR. Evaluation of the infectivity, immunogenicity and efficacy of live cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in adult volunteers. J Infect Dis. 1990;161:869-77.